BCR-ABL-IN-3

Modify Date: 2024-01-02 18:24:19

BCR-ABL-IN-3 Structure
BCR-ABL-IN-3 structure
Common Name BCR-ABL-IN-3
CAS Number 2240191-12-0 Molecular Weight 466.89
Density N/A Boiling Point N/A
Molecular Formula C20H17ClF2N4O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BCR-ABL-IN-3


BCR-ABL-IN-3 is a potent and irreversible Bcr-Abl inhibitor with an IC50 of ≤100 nM for Ba/F3Bcr-AblT3151. BCR-ABL-IN-3 has anti-cancer activity[1].

 Names

Name BCR-ABL-IN-3

 BCR-ABL-IN-3 Biological Activity

Description BCR-ABL-IN-3 is a potent and irreversible Bcr-Abl inhibitor with an IC50 of ≤100 nM for Ba/F3Bcr-AblT3151. BCR-ABL-IN-3 has anti-cancer activity[1].
Related Catalog
Target

Ba/F3Bcr-AblT3151:≤100 nM (IC50)

In Vivo BCR-ABL-IN-3 (compound 7; 15 mg/kg; twice a day; for 19 days) has good antitumor effect in female NOD/SCID mice of 7-8 weeks weighing 21.8 g with Ba/F3Bcr-AblT3151 cells[1]. BCR-ABL-IN-3 (2 mg/kg for IV or 20mg/kg for PO) has a Cmax of 5485 ng/mL and an AUC of 5450 h•ng/mL for IV in male Sprague Dawley rats of 7-8 weeks old weighing 210 g[1].
References

[1]. Hanyi Wang, et al. (hetero)arylamide compound for inhibiting protein kinase activity. WO2018133826A1.

 Chemical & Physical Properties

Molecular Formula C20H17ClF2N4O3S
Molecular Weight 466.89
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.